SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL5511]
GTX635689
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Other Application
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL5511]
- Delivery Days Customer9
- Antibody SpecificityThis antibody detects SARS-CoV-2 nucleocapsid protein, but does not cross-react with SARS-CoV or MERS-CoV nucleocapsid proteins based on our internal testing. Gold conjugation version is available upon request.This antibody is able to detect multiple SARS
- Application Supplier NoteWB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHL5511
- Concentration1 mg/ml
- ConjugateUnconjugated
- FormulationLiquid
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis. Yoo JS et al., 2021 Nov 15, Nat CommunRead more
- Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes. Lee CY et al., 2021 Sep 13, Int J Mol SciRead more
- ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication. Qu Y et al., 2021, Front Cell Dev BiolRead more
- SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles. Plescia CB et al., 2021 Jan-Jun, J Biol ChemRead more